Eiken Chemical Co., Ltd. (TYO:4549)

Market Cap	76.82B
Revenue (ttm)	40.20B
Net Income (ttm)	2.18B
Shares Out	33.90M
EPS (ttm)	61.98
PE Ratio	36.56
Forward PE	23.55
Dividend	54.00 (2.33%)
Ex-Dividend Date	Mar 28, 2025

Volume	52,800
Average Volume	103,475
Open	2,297.00
Previous Close	2,316.00
Day's Range	2,250.00 - 2,297.00
52-Week Range	1,849.00 - 2,568.00
Beta	0.10
RSI	57.36
Earnings Date	May 13, 2025

About Eiken Chemical

Eiken Chemical Co., Ltd. engages in the manufacturing and sale of clinical diagnostics in Japan. It offers microbiological reagents for diagnosis of microorganism infection, such as mediums, antimicrobial susceptibility, and rapid test reagents; urinalysis test strips for occult blood, protein, and glucose; and fecal immunochemical tests reagents for screening of colorectal cancer. The company also provides immunological and serological reagents to detect and monitor infectious disease, rheumatism, inflammation, atrophic gastritis, and prostate...

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 1939
• Employees: 757
• Stock Exchange: Tokyo Stock Exchange
• Ticker Symbol: 4549

Financial Performance

In 2023, Eiken Chemical's revenue was 40.05 billion, a decrease of -7.44% compared to the previous year's 43.27 billion. Earnings were 2.63 billion, a decrease of -54.08%.